PIK3CA overexpression is a possible prognostic factor for favorable survival in ovarian clear cell carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

PIK3CA overexpression is a possible prognostic factor for favorable survival in ovarian clear cell carcinoma

Published:2013-02 Issue:2 Volume:44 Page:199-207
ISSN:0046-8177
Container-title:Human Pathology
language:en
Short-container-title:Human Pathology

Author:

Abe Azusa,Minaguchi Takeo,Ochi Hiroyuki,Onuki Mamiko,Okada Satoshi,Matsumoto Koji,Satoh Toyomi,Oki Akinori,Yoshikawa Hiroyuki

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference18 articles.

1. Ovarian cancer;Cho;Annu Rev Pathol,2009

2. Clinicopathologic analysis of breast cancers with PIK3CA mutations in Japanese women;Maruyama;Clin Cancer Res,2007

3. PIK3CA mutations and PTEN loss correlate with similar prognostic factors and are not mutually exclusive in breast cancer;Perez-Tenorio;Clin Cancer Res,2007

4. PIK3CA mutation associates with improved outcome in breast cancer;Kalinsky;Clin Cancer Res,2009

5. PIK3CA mutations associated with gene signature of low mTORC1 signaling and better outcomes in estrogen receptor-positive breast cancer;Loi;Proc Natl Acad Sci U S A,2010

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Review the progression of ovarian clear cell carcinoma from the perspective of genomics and epigenomics;Frontiers in Genetics;2023-02-16

2. Clinical analysis and literature review of a case of ovarian clear cell carcinoma with PIK3CA gene mutation: A case report;Medicine;2022-09-16

3. Clinicopathologic significance of DNA mismatch repair protein status in endometrial cancer;Taiwanese Journal of Obstetrics and Gynecology;2022-05

4. Differential roles of the Wip1–p38–p53 DNA damage response pathway in early/advanced-stage ovarian clear cell carcinomas;World Journal of Surgical Oncology;2022-04-30

5. Correlation of PIK3CA mutation with programmed death ligand-1 (PD-L1) expression and their clinicopathological significance in colorectal cancer;Annals of Translational Medicine;2021-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3